Chad M. VanDenBerg, PharmD, MS

Midwestern University Clinical Research Services

Disclosure(s): No financial relationships to disclose

Poster(s):

• 286 - Prevalence and Clinical Outcomes of COVID-Associated Pulmonary Fibrosis
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 898 - Development of Risk Score to Guide Therapy for Carbapenem-resistant Pathogens
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET